Usefulness of Reticulocyte Hemoglobin Equivalent in Management of Regular Hemodialysis Patients with Iron Deficiency Anemia

Autor: Naomi Niari Dalimunthe, Abdurrahim Rasyid Lubis
Rok vydání: 2016
Předmět:
Male
Reticulocytes
endocrine system diseases
030204 cardiovascular system & hematology
Hematocrit
Gastroenterology
Ferric Compounds
Cohort Studies
Glucaric Acid
Hemoglobins
iron deficiency
0302 clinical medicine
Medicine
Prospective Studies
Internal medicine
Ferric Oxide
Saccharated

medicine.diagnostic_test
Anemia
Iron-Deficiency

Area under the curve
Transferrin
reticulocyte
Iron deficiency
Middle Aged
anemia
Treatment Outcome
Female
medicine.drug
Adult
congenital
hereditary
and neonatal diseases and abnormalities

endocrine system
medicine.medical_specialty
Anemia
Iron sucrose
03 medical and health sciences
Renal Dialysis
Humans
neoplasms
business.industry
Transferrin saturation
medicine.disease
RC31-1245
Iron-deficiency anemia
ROC Curve
Ferritins
Hematinics
Kidney Failure
Chronic

Hemoglobin
business
Biomarkers
030215 immunology
Zdroj: Romanian Journal of Internal Medicine, Vol 54, Iss 1, Pp 31-36 (2016)
ISSN: 1220-4749
Popis: Introduction. Reticulocyte hemoglobin equivalent (RET-He) is a new parameter for evaluating iron status. This study aims to assess diagnostic value and investigate RET-He as early predictor of response to intravenous iron supplementation. Methods. Seventy-two regular hemodialysis patients at Adam Malik Hospital were studied from April to May 2011. RET-He was compared with conventional iron parameters for identification of iron deficiency. Fifteen patients with iron deficiency anemia were selected to receive 100 mg iron sucrose intravenous during every dialysis session (2x/weeks) for 4 weeks. Results. Receiver operating characteristic (ROC) curve for RET-He revealed the value of area under the curve was 0.818 (p < 0.0001). Using cutoff level 31.65 pg, RET-He showed 81.5% sensitivity and 61.6% specificity. Serum ferritin (r = 0.499, p < 0.0001) and transferrin saturation/ TSAT (r = 0.592, p Conclusion. RET-He is a useful marker of iron deficiency and early predictor of response to intravenous iron supplementation in regular hemodialysis patients.
Databáze: OpenAIRE